A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial (Q34571072)

3 August 2017

title

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial (English)

1 reference

3 August 2017

main subject

phase I clinical trial

0 references

Ebola vaccine

0 references

Orthoebolavirus zairense

0 references

1 reference

15

Gary J Nabel

1 reference

3 August 2017

16

Barney S Graham

1 reference

3 August 2017

5

Mario Roederer

1 reference

3 August 2017

3

Mary E Enama

1 reference

3 August 2017

4

Ingelise J Gordon

1 reference

3 August 2017

6

Richard A Koup

1 reference

3 August 2017

2

Nancy J Sullivan

1 reference

3 August 2017

8

Bimal K Chakrabarti

1 reference

3 August 2017

12

Zoe Moodie

1 reference

3 August 2017

Julie E Martin

1

1 reference

3 August 2017

Robert T Bailer

7

1 reference

3 August 2017

Michael A Bailey

9

1 reference

3 August 2017

Phillip L Gomez

10

1 reference

3 August 2017

Charla A Andrews

11

1 reference

3 August 2017

Lin Gu

13

1 reference

3 August 2017

Judith A Stein

14

1 reference

3 August 2017

language of work or name

1 reference

20 September 2006

1 reference

Clinical and Vaccine Immunology

3 August 2017

published in

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

1267-1277

1 reference

describes a project that uses

3 August 2017

ImageQuant

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC1656552/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Fruit bats as reservoirs of Ebola virus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Towards a vaccine against Ebola virus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Ebola virus pathogenesis: implications for vaccines and therapies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Vaccine research efforts for filoviruses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Ebola virus: the search for vaccines and treatments

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Bioterrorism--biotechnology to the rescue?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Induction of CD4( ) T cell-dependent CD8( ) type 1 responses in humans by a malaria DNA vaccine.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Development of a preventive vaccine for Ebola virus infection in primates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Immunization for Ebola virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

An Ebola epidemic simmers in Africa: in remote region, outbreak shows staying power

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Ebola: small, but real progress

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Induction of antigen-specific CD8 T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

Pathogenesis of experimental Ebola virus infection in guinea pigs

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

An improved plasmid DNA expression vector for direct injection into skeletal muscle

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1656552

27 October 2018

Identifiers

DOI

10.1128/CVI.00162-06

1 reference

3 August 2017

1 reference

3 August 2017

1 reference